Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

thomas_headshot

BMS finds replacement for retiring CSO

March 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb

Bristol-Myers Squibb has announced the appointment of Dr. Thomas J. Lynch, Jr., to the position of Executive Vice President and …
Appointment
kingscollegechapelwest

Cambridge University announces ‘world-leading’ industry-academia collaboration initiative

March 9, 2017 Medical Communications, Research and Development University of Cambridge

The University of Cambridge has announced a new initiative that seeks to build a bridge between industry and academia in …
News
charity_gifts_for_children_with_cancer_foundation_vanessa_isabel

Looming Brexit sparks fears for child cancer trials, experts warn

March 9, 2017 Medical Communications, Research and Development EU, ICR, brexit

The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …
News
park-profile-trans

Keapstone Therapeutics created out of Sheffield Uni and Parkinson’s UK link

March 8, 2017 Research and Development Keapstone therapeutics, Parkinson's UK, University of Sheffield

The University of Sheffield and Parkinson’s UK has created, in a first-of-a-kind, a virtual biotech company for developing therapies against …
News
acute_leukemia-all

New drug combination gives hope for acute myeloid leukaemia treatment

March 8, 2017 Research and Development acute myeloid leukaemia

A new trial in the US hopes to marry a new pair of drugs as a combination treatment for acute …
News
trevor-philips

Vectura’s COO set to step down

March 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …
Appointment
amgen_hq

FDA and NICE approve of first new hyperparathyroidism drug in 12 years

March 8, 2017 Research and Development, Sales and Marketing FDA, NICE, Parsabiv, hyperparathyroidism

The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients …
News
web_scientist-filling-out-form---credit-national-institutes-of-health

Diabetes drug could be key to treating aggressive breast cancer, research suggests

March 8, 2017 Research and Development Cancer, diabetes

Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …
News
child

Research gives hope of potential treatment for most deadly paediatric brain tumour

March 8, 2017 Research and Development

A study conducted by researchers from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has given …
News
gdd_logo_002

BeiGene to develop $330 million biologics plant

March 7, 2017 Manufacturing and Production, Research and Development BeiGene, China, Guangzhou

BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …
News
shutterstock_38078521

Researchers discover worrying new antibiotic-resistance gene variant

March 7, 2017 Manufacturing and Production, Research and Development drug resistance

A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered …
News
europe_tied_in_knots

Negotiating the EU pricing system: How the financial crisis has encouraged closer-knit cooperation between member states

March 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, pricing

Drug pricing is a topic that has become headline-friendly over the past year. It has come to dominate media coverage …
Feature

Lilly posts impressive psoriasis results in comparison study

March 6, 2017 Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly

Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …
News
janssen_latest_logo_on_sign_closer

Phase 3 data for Janssen psoriasis drug shows efficacy over Humira

March 6, 2017 Research and Development, Sales and Marketing Humira, Janssen, guselkumab, psoriasis

Janssen has revealed new Phase 3 data for its human monoclonal antibody guselkumab in the treatment of adults with moderate …
News

Bioverativ adds new member to board of directors

March 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biogen spinout, Bioverativ, have moved to consolidate its board of directors by appointing Anna Protopapas to the board. Protopapas becomes …
Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026